Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates
NCT06908616 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-04-06
Summary
This is a prospective observational study designed to assess the prevalence of the Duffy null phenotype (associated with ethnic neutropenia) in neonates born at Kaplan Medical Center. Blood samples will be collected from umbilical cords (non-invasively) to evaluate Duffy antigen expression. Data on ethnicity, perinatal factors, and routine blood counts at 9-12 months (when available) will also be collected to correlate phenotype with absolute neutrophil count (ANC).
Conditions
- Neutropenia (Low White Blood Cell Count)
Interventions
- DIAGNOSTIC_TEST
-
Cord blood
Cord blood samples will be collected during routine G6PD testing. An additional 3 mL will be obtained non-invasively from the umbilical cord to determine the expression of Duffy antigens using serologic gel testing.
Sponsors & Collaborators
-
Kaplan Medical Center
lead OTHER
Principal Investigators
-
Tal Ben Ami, MD · Kaplan Medical Center
Eligibility
- Min Age
- 1 Minute
- Max Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-08
- Primary Completion
- 2026-12-31
- Completion
- 2027-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients
NCT03530072 ·Status: COMPLETED
-
Early Antibiotic Discontinuation in FUO
NCT02906254 ·Status: COMPLETED
-
Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
NCT02536599 ·Status: UNKNOWN
-
Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder
NCT05689450 ·Status: COMPLETED
-
Fever and Neutropenia in Pediatric Oncology Patients
NCT03768869 ·Status: WITHDRAWN ·Phase: PHASE3
-
Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia
NCT01450241 ·Status: WITHDRAWN ·Phase: NA
-
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca
NCT04662892 ·Status: UNKNOWN
-
Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
NCT02178475 ·Status: COMPLETED
-
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
NCT00883181 ·Status: COMPLETED
-
Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia
NCT01658956 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer
NCT00277160 ·Status: COMPLETED ·Phase: PHASE4
-
Antimicrobial Revision in Persistent Febrile Neutropenia
NCT05784844 ·Status: WITHDRAWN ·Phase: PHASE4
-
Daptomycin Versus Placebo in Patients With Neutropenia and Fever
NCT01216241 ·Status: TERMINATED ·Phase: PHASE3
-
The Oral Cavity as a Source of Febrile Neutropenia
NCT02702583 ·Status: COMPLETED
-
Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia
NCT02463747 ·Status: UNKNOWN ·Phase: PHASE4
-
Short Antibiotic Treatment in High Risk Febrile Neutropenia
NCT05786495 ·Status: RECRUITING ·Phase: NA
-
Pediatric FN Definition 2012 Bern
NCT01683370 ·Status: COMPLETED
-
Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy
NCT00111462 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
NCT06510868 ·Status: RECRUITING
-
Cardiovascular Manifestations in Ph-negative MPN
NCT06615414 ·Status: NOT_YET_RECRUITING
-
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
NCT02856204 ·Status: COMPLETED
-
Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein
NCT02465801 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
NCT01674855 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study
NCT01763398 ·Status: COMPLETED
-
A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)
NCT02766634 ·Status: COMPLETED ·Phase: PHASE1